[Effect of inflammation mediators and antirheumatic drugs on the production of superoxide anion (O2-) by polymorphonuclear cells in normals and rheumatoid arthritis].
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000527:Alprostadil; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D001172:Arthritis, Rheumatoid / Q000097:blood*; D000242:Cyclic AMP / Q000494:pharmacology; D006152:Cyclic GMP / Q000494:pharmacology; D006801:Humans; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D010100:Oxygen / Q000097:blood*; D011458:Prostaglandins E / Q000494:pharmacology; D013481:Superoxides / Q000097:blood*; D013806:Theophylline / Q000494:pharmacology
D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D011458:Prostaglandins E; D013481:Superoxides; D013806:Theophylline; D000242:Cyclic AMP; D000527:Alprostadil; D006152:Cyclic GMP; D010100:Oxygen
Effetto dei mediatori della flogosi i dei farmaci antireumatici sulla produzione di superossido-anione (O2-) da parte dei polimorfonucleati normali e di artrite reumatoide.